Mainland Chinese market for weight loss and diabetes drugs to soon be more crowded: report
diabetes and weight loss
drugs is set to intensify as more than 60 late-stage drug candidates are undergoing clinical trials, according to a recent report.
Up to 20 biosimilar or generic copies will vie for market share and add pricing pressure after Denmark-based Novo Nordisk's semaglutide product loses patent protection in China next year, according to Boston-based global consultancy L.E.K. Consulting. Novo Nordisk's patent will expire in 2031 in Japan and Europe and 2032 in the US, according to its latest annual report.
'The landscape in China is expected to become even more competitive than in developed markets, where the GLP-1 category is primarily dominated by leading multinational pharmaceutical companies,' said Helen Chen, L.E.K.'s global healthcare and life sciences co-head, in a report on May 15.
GLP-1 drugs mimic natural hormones, which signal the pancreas to release more insulin when blood-sugar levels are high, and also support weight loss by slowing digestion and reducing appetite.
04:12
One reporter's weight-loss journey and what a 'healthy body' means to him
One reporter's weight-loss journey and what a 'healthy body' means to him
Driven by sales growth of semaglutide, Novo Nordisk became the 10th largest drug company in the world in terms of revenue. London-based consultancy Evaluate said the firm's revenue rose 25 per cent to US$42.1 billion last year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
6 minutes ago
- South China Morning Post
As the US and China compete, Asean could play arbiter
As Asean celebrates its 58th anniversary, it is inhabiting a liminal moment, one that straddles the unmarked border between two international eras. One era is lingering but on its way out as another is hobbling its way in. The Cold War is long gone and the subsequent period of American unipolar primacy is drawing to a close, albeit without a new global order to replace it. The great powers are in the throes of an inevitable transition. The United States and China each believe that history is on its side. Southeast Asian countries do not believe that the global highways of military and financial power have bypassed the US forever or that they should put all their eggs in China's basket. History is still in flux. The rules-based global order is like a highway under tensile stress, particularly in the Indo-Pacific region, perhaps the most congested junction on the highway between the US and China. The Association of Southeast Asian Nations stands at the heart of that junction. The safety of the highway depends on its structural integrity. The safety of regions along the highway depends on great powers following the rules of the road. However, there is no longer one set of rules. The traffic laws of international affairs now have many different interpretations. Increasingly, the US and China insist on adherence to a rules-based order on their own respective terms and for their respective interests. Interpretations must be reconciled so international traffic can flow safely and smoothly. Asean can encourage both sides to adopt a common highway code for mutual security. Of course, Asean is no global policeman. But it's precisely because Asean poses no economic, political or military threat to either the US or China, or to anyone else, that it can act as an informal and impartial interlocutor between the two great powers. That should be Asean's diplomatic purpose: to be an arbiter in the Indo-Pacific region. Southeast Asia is still a price-taker in international relations. However, the escalating Sino-US rivalry has turned the world from a seller's market into a buyer's one. The more intense that rivalry gets, the more that great powers feel the need to 'sell' themselves to others.
South China Morning Post
36 minutes ago
- South China Morning Post
Tencent game studio eyes global growth with Honour of Kings spin-off after user milestone
Tencent Holdings , the world's largest video gaming company by revenue, is intensifying its international expansion as its flagship studio reports a record number of overseas players and prepares to launch a new title based on its flagship game, Honour of Kings Advertisement TiMi Studio Group – developer of Honour of Kings, Call of Duty: Mobile, and Delta Force – has reached 100 million monthly active users outside mainland China, a milestone that took the 17-year-old studio by surprise, according to Huang Shuo, TiMi's global publishing director, in a recent interview with the South China Morning Post. This marks the first time TiMi has disclosed its overseas user numbers. As a key revenue driver for Tencent's extensive gaming operations, the studio is doubling down on global expansion with the coming multiplayer adventure action role-playing game (RPG), Honour of Kings: World. Video gaming is a key revenue source for China's most valuable tech conglomerate, which is aiming to boost overseas gaming sales as the domestic market begins to plateau. Tencent's latest financial results showed that its international game revenue surged 35 per cent in the second quarter from a year earlier, while domestic game revenue rose 17 per cent during the same period. TiMi Studio is one of Tencent's key revenue drivers. Photo: Handout In recent years, Beijing has softened its regulatory stance on video games. While China enforces strict licensing and limits game time for players under 18 to three hours per week, authorities increasingly view local games as symbols of the country's soft power, especially following the success of Black Myth: Wukong.
South China Morning Post
an hour ago
- South China Morning Post
Hong Kong exchange's confidential filing option lures tech listing hopefuls, law firm says
Nearly half of the biotech and technology start-ups seeking initial public offerings (IPOs) in Hong Kong are opting for confidential filings under a new listing channel that allows them to protect sensitive data, according to a lawyer with international law firm Cooley. Advertisement Companies choosing confidential filings often have concerns about sensitive information being released to the market in the early stages of the IPO process, which could attract scrutiny or allegations from competitors, Michael Yu, corporate partner at the firm, said in an interview. 'Some worry that, if they make a public filing, competitors or other parties will discover their listing timeline and could make complaints or take advantage of what is disclosed,' he said. 'There is always a risk of allegations, intellectual property infringement or challenges to the accuracy of their data.' The stock exchange 's new regime helped companies sidestep such issues, which could speed up the IPO application process, he said. 'About 50 per cent of companies that are eligible to raise funds under Chapters 18A and 18C are choosing confidential filings,' Yu said. Reuters earlier reported that at least two dozen Chinese companies had confidentially filed to list in Hong Kong this year. Advertisement
